Bonus BioGroup Ltd.
BBIXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $85 | $85 | $205 | $1,338 |
| - Cash | $7 | $13 | $54 | $79 |
| + Debt | $10 | $11 | $12 | $12 |
| Enterprise Value | $88 | $83 | $163 | $1,271 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$3 | -$4 |
| % Margin | – | – | – | – |
| EBITDA | -$26 | -$28 | -$35 | -$88 |
| % Margin | – | – | – | – |
| Net Income | -$28 | -$29 | -$39 | -$90 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.024 | -0.024 | -0.033 | -0.078 |
| % Growth | 2.5% | 26.3% | 57.6% | – |
| Operating Cash Flow | -$21 | -$26 | -$29 | -$40 |
| Capital Expenditures | -$0 | -$1 | -$6 | -$6 |
| Free Cash Flow | -$22 | -$27 | -$35 | -$46 |